Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
Clinical trial NCT00351923 · COMPLETED
Trial details
- NCT number
- NCT00351923
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.